Health Condition 1: I83- Varicose veins of lower extremities
Conditions
Interventions
Intervention1: Individualized homoeopathic medicines: Based on severity and totality of each patients specific symptoms, followed by consultation of symptoms with Materia Medica and repertorial analys
Sponsors
Dr Meenakshi Gupta
Eligibility
Inclusion criteria
Inclusion criteria: Clinically diagnosed patients with varicose veins, patients willing to participate in study and providing written informed consent
Exclusion criteria
Exclusion criteria: Associated comorbidities: Patients with associated medical conditions like any severe systemic illness, chronic communicable/non-communicable diseases, moderate to severe acute infectious condition, or any organ failure; Any vascular conditions that may impact findings of study including e.g. Atherosclerosis, Deep Vein Thrombosis, history of CVA, Peripheral Artery Disease, or any hypercoagulable state; Patients with the history of taking any medication for varicose veins within a period of 2 weeks before starting study; Special Population: Pregnant and lactating women, paediatric and geriatric patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement in symptoms of varicose veins and quality of life of patientsTimepoint: After inclusion, patients will be followed-up preferably after 2 weeks, 1 month, 2 months and 3 months from inclusion, as and when required. Patients visits may vary depending upon individualized therapy and patients clinical condition, except final visit at 3 months. VCSS scale and AVVQ questionnaire will be applied at the time of inclusion and at the completion of follow-up period, i.e., 3 months. Changes in symptomatology and scores will be noted and analysed. | — |
Secondary
| Measure | Time frame |
|---|---|
| Identify most frequently used homoeopathic medicines in treating varicose veinsTimepoint: At inclusion, patient clinical condition will be analysed & individualized homoeopathic medicines or placebo will be prescribed to the subject for varicose veins. Frequency of each drug prescribed in study will be analysed to find out drugs frequently used drugs to treat varicose veins. After inclusion, patients will be followed-up preferably after 2 weeks, 1 month, 2 months & 3 months from inclusion, as & when required depending upon individualized therapy & patients clinical condition. | — |
Countries
India
Contacts
Public ContactDr Meenakshi Gupta
Sri Ganganagar Homoeopathic Medical College Hospital and Research Institute
Outcome results
None listed